ctrl K

Price Alert

Janux Therapeutics Inc. (JANX)

NASDAQ: JANX · Real-Time Price · USD

25.04

0.07 (0.28%)

At close: Aug 15, 2025, 3:59 PM

25.11

0.30%

After-hours: Aug 15, 2025, 04:34 PM EDT

Janux Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	430.61M	19.2M	51.43M	35.58M
Short-Term Investments	594.57M	324.82M	275.59M	339.38M
Long-Term Investments	n/a	n/a	816K	816K
Other Long-Term Assets	3.7M	3.33M	1.39M	392K
Receivables	5.38M	2.16M	700K	200K
Inventory	n/a	n/a	-700K	-200K
Other Current Assets	n/a	n/a	5.42M	n/a
Total Current Assets	1.03B	349.24M	332.44M	377.02M
Property-Plant & Equipment	24.15M	27.84M	29.36M	1.6M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	27.85M	31.17M	31.57M	2.81M
Total Assets	1.06B	380.41M	364.01M	379.82M
Account Payables	4.03M	2.42M	2.16M	2.46M
Deferred Revenue	n/a	1.71M	5.41M	5.16M
Short-Term Debt	1.75M	n/a	n/a	194K
Other Current Liabilities	9.94M	3.3M	5.51M	3.62M
Total Current Liabilities	17.46M	13.03M	16.51M	12.8M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	21.28M	23.02M	26.76M	700K
Total Liabilities	38.73M	36.06M	43.27M	13.5M
Total Debt	23.02M	24.54M	25.3M	194K
Common Stock	59K	46K	42K	41K
Retained Earnings	-237.76M	-168.76M	-110.47M	-47.41M
Comprehensive Income	2.16M	665K	-1.53M	-270K
Shareholders Equity	1.02B	344.35M	320.74M	366.33M
Total Investments	594.57M	324.82M	275.59M	339.38M